Dr. Brooke Elizabeth Sanders, MD

Dr. Sanders practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Sanders' NPI, 1265896336, was assigned on April 5, 2016. Dr. Sanders graduated from University of California, Irvine, California College of Medicine in 2016. Dr. Sanders holds Missouri license 2023012318.

Dr. Sanders' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Sanders also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Sanders' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Sanders is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Sanders to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanders practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Sanders' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Sanders is licensed in Missouri.

CMS data shows 14,294 Medicare services from Dr. Sanders across 19 procedure codes in 2024, for 206 Medicare patients. Medicare paid $41,050 for them.

CMS counts 206 Medicare patients who saw Dr. Sanders in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanders' median patient age at 69, with 100% women.

In 2024, Dr. Sanders wrote 432 Medicare Part D claims for 92 patients. 90% of them were for generic drugs. CMS names the drug for 234 of them, across 9 drugs with 11 or more claims each, at $2,968 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sanders for performance year 2024, reported as part of a group. Dr. Sanders accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanders as offering telehealth. CMS counts 19 procedures of removal of the uterus by Dr. Sanders, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Sanders, published from 2015 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms. Dr. Sanders has published most often in Gynecol Oncol Rep. Dr. Sanders' most frequent co-authors are Kian Behbakht, MD, Amber Atwood Berning, MD and Lindsay Brubaker, MD.

CMS Open Payments shows 21 general payments to Dr. Sanders from 8 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Genmab U.S., Inc. paid the most, $126.

Dr. Sanders graduated from University of California, Irvine, California College of Medicine in 2016.